story of the week
Androgen Receptor Pathway Inhibitors and Taxanes for Metastatic Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
Nat. Med. 2024 Aug 20;[EPub Ahead of Print], B De Laere, A Crippa, A Discacciati, B Larsson, M Persson, S Johansson, S D'hondt, R Bergström, V Chellappa, M Mayrhofer, M Banijamali, A Kotsalaynen, C Schelstraete, JP Vanwelkenhuyzen, M Hjälm-Eriksson, L Pettersson, A Ullén, N Lumen, G Enblad, C Thellenberg Karlsson, E Jänes, J Sandzén, P Schatteman, M Nyre Vigmostad, M Olsson, C Ghysel, B Sautois, W De Roock, S Van Bruwaene, M Anden, I Verbiene, D De Maeseneer, E Everaert, J Darras, BY Aksnessether, D Luyten, M Strijbos, A Mortezavi, J Oldenburg, P Ost, M Eklund, H Grönberg, J LindbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.